INTEGRATED DEVICE TECHNOLOGY, INC. | ||||||||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (a) | ||||||||||
(Unaudited) | ||||||||||
(In thousands, except per share data) |
|
|
|
|
|
|
|
|
| |
|
| Three Months Ended |
| Six Months Ended | ||||||
|
| Sep. 30, 2018 |
| Jul. 1, 2018 |
| Oct. 1, 2017 |
| Sep. 30, 2018 |
| Oct. 1, 2017 |
GAAP net income |
| $ 35,500 |
| $ 30,720 |
| $ 18,680 |
| $ 66,220 |
| $ 35,394 |
GAAP diluted net income per share |
| $ 0.26 |
| $ 0.23 |
| $ 0.14 |
| $ 0.49 |
| $ 0.26 |
Acquisition-related: |
|
|
|
|
|
|
|
|
|
|
Amortization of acquisition-related intangibles |
| 9,365 |
| 9,334 |
| 8,963 |
| 18,699 |
| 17,839 |
Acquisition-related costs |
| - |
| - |
| - |
| - |
| 2,225 |
Amortization of fair market value adjustment to inventory |
| - |
| 790 |
| 2,011 |
| 790 |
| 6,092 |
Merger-related expense |
| 3,884 |
| - |
| - |
| 3,884 |
| - |
Restructuring-related: |
|
|
|
|
|
|
|
|
|
|
Severance costs |
| 1,351 |
| 367 |
| 1,637 |
| 1,718 |
| 2,290 |
Facility closure costs (benefit) |
| (125) |
| 121 |
| 2,542 |
| (4) |
| 2,542 |
Assets impairment and other |
| - |
| - |
| 917 |
| - |
| 2,882 |
Other: |
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
| 15,637 |
| 15,063 |
| 12,950 |
| 30,700 |
| 24,770 |
Non-cash interest expense |
| 3,881 |
| 3,955 |
| 3,695 |
| 7,836 |
| 7,587 |
Other-than-temporary impairment loss on investment |
| - |
| 2,000 |
| - |
| 2,000 |
| - |
Certain unrealized foreign exchange loss (gain) |
| (144) |
| 1,311 |
| (754) |
| 1,167 |
| (2,429) |
Compensation expense - deferred compensation plan |
| 654 |
| 576 |
| 469 |
| 1,230 |
| 881 |
Gain on deferred compensation plan securities |
| (650) |
| (564) |
| (443) |
| (1,214) |
| (803) |
Non-GAAP tax adjustments |
| (5,892) |
| (3,538) |
| (2,518) |
| (9,430) |
| (5,859) |
Non-GAAP net income |
| $ 63,461 |
| $ 60,135 |
| $ 48,149 |
| $ 123,596 |
| $ 93,411 |
GAAP weighted average shares - diluted |
| 134,755 |
| 132,806 |
| 136,059 |
| 133,957 |
| 136,434 |
Non-GAAP adjustment |
| 1,214 |
| 2,378 |
| 2,780 |
| 2,013 |
| 2,465 |
Non-GAAP weighted average shares - diluted |
| 135,969 |
| 135,184 |
| 138,839 |
| 135,970 |
| 138,899 |
Non-GAAP diluted net income per share |
| $ 0.47 |
| $ 0.44 |
| $ 0.35 |
| $ 0.91 |
| $ 0.67 |
|
|
|
|
|
|
|
|
|
|
|
GAAP gross profit |
| $ 143,584 |
| $ 136,607 |
| $ 116,762 |
| $ 280,191 |
| $ 226,800 |
Acquisition-related: |
|
|
|
|
|
|
|
|
|
|
Amortization of acquisition-related intangibles |
| 6,274 |
| 6,243 |
| 5,822 |
| 12,517 |
| 11,504 |
Amortization of fair market value adjustment to inventory |
| - |
| 790 |
| 2,011 |
| 790 |
| 6,092 |
Restructuring-related: |
|
|
|
|
|
|
|
|
|
|
Severance costs |
| 397 |
| - |
| 30 |
| 397 |
| 226 |
Other: |
| - |
|
|
|
|
| - |
|
|
Compensation expense - deferred compensation plan |
| 153 |
| 135 |
| 110 |
| 288 |
| 207 |
Stock-based compensation expense |
| 829 |
| 1,028 |
| 764 |
| 1,857 |
| 1,396 |
Non-GAAP gross profit |
| $ 151,237 |
| $ 144,803 |
| $ 125,499 |
| $ 296,040 |
| $ 246,225 |
|
|
|
|
|
|
|
|
|
|
|
GAAP R&D expenses: |
| $ 55,509 |
| $ 52,234 |
| $ 48,742 |
| $ 107,743 |
| $ 97,191 |
Restructuring-related: |
|
|
|
|
|
|
|
|
|
|
Severance costs |
| (587) |
| (110) |
| (318) |
| (697) |
| (363) |
Facility closure costs |
| (315) |
| - |
| - |
| (315) |
| - |
Assets impairment and other |
| - |
| - |
| (835) |
| - |
| (2,800) |
Other: |
|
|
|
|
|
|
|
|
|
|
Compensation expense - deferred compensation plan |
| (334) |
| (294) |
| (239) |
| (628) |
| (449) |
Stock-based compensation expense |
| (7,829) |
| (7,136) |
| (6,094) |
| (14,965) |
| (12,057) |
Non-GAAP R&D expenses |
| $ 46,444 |
| $ 44,694 |
| $ 41,256 |
| $ 91,138 |
| $ 81,522 |
|
|
|
|
|
|
|
|
|
|
|
GAAP SG&A expenses: |
| $ 46,753 |
| $ 42,995 |
| $ 44,485 |
| $ 89,748 |
| $ 86,427 |
Acquisition-related: |
|
|
|
|
|
|
|
|
|
|
Amortization of acquisition-related intangibles |
| (3,091) |
| (3,091) |
| (3,141) |
| (6,182) |
| (6,335) |
Acquisition-related costs |
| - |
| - |
| - |
| - |
| (2,225) |
Merger-related expense |
| (3,884) |
| - |
| - |
| (3,884) |
| - |
Restructuring-related: |
|
|
|
|
|
|
|
|
|
|
Severance costs |
| (367) |
| (257) |
| (1,289) |
| (624) |
| (1,701) |
Facility closure benefit (costs) |
| 440 |
| (121) |
| (2,542) |
| 319 |
| (2,542) |
Assets impairment and other |
| - |
| - |
| (82) |
| - |
| (82) |
Other: |
|
|
|
|
|
|
|
|
|
|
Compensation expense - deferred compensation plan |
| (167) |
| (147) |
| (120) |
| (314) |
| (225) |
Stock-based compensation expense |
| (6,979) |
| (6,899) |
| (6,092) |
| (13,878) |
| (11,317) |
Non-GAAP SG&A expenses |
| $ 32,705 |
| $ 32,480 |
| $ 31,219 |
| $ 65,185 |
| $ 62,000 |
|
|
|
|
|
|
|
|
|
|
|
GAAP interest and other expense, net |
| $ (4,608) |
| $ (5,514) |
| $ (4,886) |
| $ (10,122) |
| $ (8,801) |
Non-cash interest expense |
| 3,881 |
| 3,955 |
| 3,695 |
| 7,836 |
| 7,587 |
Gain on deferred compensation plan securities |
| (650) |
| (564) |
| (443) |
| (1,214) |
| (803) |
Certain unrealized foreign exchange loss (gain) |
| (144) |
| 1,311 |
| (754) |
| 1,167 |
| (2,429) |
Non-GAAP interest and other expense, net |
| $ (1,521) |
| $ (812) |
| $ (2,388) |
| $ (2,333) |
| $ (4,446) |
|
|
|
|
|
|
|
|
|
|
|
GAAP benefit from (provision for) income taxes |
| $ (1,214) |
| $ (3,144) |
| $ 31 |
| $ (4,358) |
| $ 1,013 |
Non-GAAP tax adjustments |
| 5,892 |
| 3,538 |
| 2,518 |
| 9,430 |
| 5,859 |
Non-GAAP provision for income taxes |
| $ (7,106) |
| $ (6,682) |
| $ (2,487) |
| $ (13,788) |
| $ (4,846) |
| ||||||||||
(a) Refer to the accompanying "Notes to Non-GAAP Financial Measures" for a detailed discussion of management's use of non-GAAP financial measures. |